NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE American · Medical Devices · USD

Electromed, Inc. (ELMD) Stock Analysis

Electromed, Inc. (ELMD) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

ELMD

$28.00

+$0.39 (+1.41%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ELMD with… →

ELMD Key Statistics

As of Sep 4, 2026
Trading
Open
$27.43
Previous Close
$27.61
Day's Range
27.07–28.14
52-Week Range
23.01–47.40
Volume
118.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.46
Valuation
Market Cap
$234.25M
P/E Ratio
21.54
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
45.90
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.35
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.18
EPS (ttm)Profit attributable to each share over the last twelve months.
1.30
Financials (FY)
Revenue (FY)
$64.00M+16.97%
Net Income (FY)
$7.54M+46.35%
Profit marginThe share of revenue left as profit after all costs and taxes.
15.32%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
8.37M
1-Year Return
+12.40%
Dividend and dates
Earnings Date
November 11, 2026
Avg Volume
103.44K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ELMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−3.85%
2025−1.46%
2024+170.85%
2023+4.00%
2022−19.31%
2021+32.52%
2020+13.41%
2019+69.94%
2018−16.14%
2017+56.44%
2016 (partial year)−9.98%

As of September 4, 2026.

ELMD Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$64.00M$7.54M11.8%
2024$54.72M$5.15M9.4%
2023$48.07M$3.17M6.6%
2022$41.66M$2.31M5.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$64.00M$49.97M$9.66M$7.54M11.8%
2024$54.72M$41.73M$6.58M$5.15M9.4%
2023$48.07M$36.52M$4.01M$3.17M6.6%
2022$41.66M$31.44M$2.97M$2.31M5.5%

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

ELMD Valuation vs Medical Devices Median

Median of 151 stocks
MetricELMDMedical Devices medianvs median
P/E21.5426.8020% below
P/S ratio3.182.987% above
Profit margin15.32%−1.69%17.0 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Electromed, Inc. (ELMD) at $234.25M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 195.

The 52-week range on file runs from $23.01 to $47.40. ELMD last closed at $28.00 on September 4, 2026. That is +$0.39 (+1.41%) against the previous close. The latest close sits 21.69% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $64.00M. That is +16.97% against the prior fiscal year, when revenue was $54.72M. Net income for the same year was $7.54M. That is +46.35% against the prior fiscal year. Profit margin runs at 15.32%. That is 17 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 1.3.

Across the 4 fiscal years on file, revenue moves from $41.66M in 2022 to $64.00M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 21.54 times earnings. That is 19.63% below the Medical Devices median of 26.8. The forward P/E on file is 45.9. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.35. Measured against sales, the shares trade at 3.18 times revenue. On price-to-sales that is 6.69% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned +12.40%. Measured over 10 years, that is +17.91% a year compounded. The reported beta is 0.46. Annualized volatility over the trailing 10 years is 53.14%.

Growth & Income

The record shows no dividend for ELMD.

The strongest complete calendar year on file is 2024 at +170.85%; the weakest is 2022 at −19.31%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is −3.85% year to date.

Peer Comparison

Electromed, Inc. (ELMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Electromed, Inc. ELMD $234.25M 21.5
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Electromed, Inc. trades at a P/E of 21.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Electromed, Inc.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Visit website →